The role of income and rurality in US cancer mortality: A SEER analysis.

W Wade T Swenson (Rural Cancer Institute, Fergus Falls, MN) E Emily McGovern (2Novartis Ireland Limited, Dublin, Ireland) Z Zachary Schroeder (University of Kansas School of Medicine, Kansas City, KS) A Abigail Paige Swenson (Medical College of Wisconsin, De Pere, WI) A Aquino Anthony Williams (Gunderson Health System, La Crosse, WI) J Jake Deviley (Gunderson Health System, La Crosse, WI) A Anika Eldien (University of Minnesota Duluth Medical School, Duluth, MN) A Andrew Armstrong (Sandia National Laboratories 2 , Albuquerque, New Mexico 87123,) S Sahil Prakash (TCU School of Medicine, Fort Worth, TX) B Brooke Gully (TCU School of Medicine, Fort Worth, TX) S Sean Kelso (TCU School of Medicine, Fort Worth, TX) I Ingrid Jacobson (University of Minnesota Rural Health Research Center, Minneapolis, MN) J Joshua C Pritchett (Mayo Clinic, Rochester, MN)

Abstract

e13828 Background: Disparities in cancer outcomes between rural and urban populations are often linked to limited healthcare resources in rural areas. However, the impact of socioeconomic factors, particularly income inequality, requires further investigation. Methods: We analyzed cancer mortality rates using the Surveillance, Epidemiology, and End Results (SEER) database, focusing on rural-urban continuum codes and median county income, the proportions of patients with de novo metastatic disease at diagnosis, those aged 80 and older, and those experiencing a treatment delay of three months or more. Results: Our findings indicate that non-metropolitan counties (56.7%, 95% CI: 56.6%, 56.8%) and those with lower median incomes (54.9%, 95% CI: 54.8%, 55.1%) have significantly lower cancer survival rates than metropolitan counties (62.6%, 95% CI: 62.5%, 62.6%) and higher-income rural counties (62.6%, 95% CI: 62.6%, 62.7%), a trend consistent over the observation period. Higher proportions of de novo metastatic disease and increased treatment delays were observed in counties with lower income and greater rurality, with these counties also demonstrating higher annual percentage rates of change for both de novo metastatic disease (P < 0.05) and treatment delays (P < 0.05). Conclusions: Lower county-level median household income is associated with higher cancer mortality rates, increased de novo metastatic disease, and longer treatment delays. These results underscore the need to appreciate the role of income disparities in cancer outcomes and to improve access to oncology care in underserved rural populations.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (13)

W

Wade T Swenson

Rural Cancer Institute, Fergus Falls, MN

E

Emily McGovern

2Novartis Ireland Limited, Dublin, Ireland

Z

Zachary Schroeder

University of Kansas School of Medicine, Kansas City, KS

A

Abigail Paige Swenson

Medical College of Wisconsin, De Pere, WI

A

Aquino Anthony Williams

Gunderson Health System, La Crosse, WI

J

Jake Deviley

Gunderson Health System, La Crosse, WI

A

Anika Eldien

University of Minnesota Duluth Medical School, Duluth, MN

A

Andrew Armstrong

Sandia National Laboratories 2 , Albuquerque, New Mexico 87123,

S

Sahil Prakash

TCU School of Medicine, Fort Worth, TX

B

Brooke Gully

TCU School of Medicine, Fort Worth, TX

S

Sean Kelso

TCU School of Medicine, Fort Worth, TX

I

Ingrid Jacobson

University of Minnesota Rural Health Research Center, Minneapolis, MN

J

Joshua C Pritchett

Mayo Clinic, Rochester, MN